Protalix BioTherapeutics
PLX
#8957
Rank
A$0.26 B
Marketcap
A$3.33
Share price
0.22%
Change (1 day)
48.16%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): A$0.02312

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is A$0.02890. In 2024 the company made an earnings per share (EPS) of A$0.05780 a decrease over its 2023 EPS that were of A$0.17.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$0.02312-60.01%
2024A$0.05780-66.67%
2023A$0.17-138.71%
2022A-$0.45-50%
2021A-$0.90181.82%
2020A-$0.32-82.11%
2019A-$1.78-31.67%
2018A-$2.60-72.31%
2017A-$9.39124.14%
2016A-$4.19-147.54%
2015A$8.82-290.63%
2014A-$4.626.67%
2013A-$4.34130.77%
2012A-$1.88-69.77%
2011A-$6.2119.44%
2010A-$5.20-12.2%
2009A-$5.9236.67%
2008A-$4.34-37.5%
2007A-$6.9450%
2006A-$4.623.23%
2005A-$4.48138.46%
2004A-$1.88-74%
2003A-$7.23-0%
2002A-$7.23-50%
2001A-$14.45233.33%
2000A-$4.34-84.21%
1999A-$27.46-24%
1998A-$36.13-600%
1997A$7.23-16.67%
1996A$8.67

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.89 6,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$9.70 33,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A-$0.16-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$1.98 6,750.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel